The evolving role of CDMOs in advanced biologics manufacturing
The pharmaceutical and biotech industries are experiencing a paradigm shift that is redefining the roles and responsibilities of Contract Development and Manufacturing Organizations (CDMOs). Over the past few decades, these ...
NorthX Plasmid Solutions
NorthX Biologics is providing expert plasmid DNA solutions for all phases ranging from early pre-clinical through to commercial manufacture. We offer a range of plasmid qualities with the right level ...
Plasmid DNA – The right quality for each application
With the tremendous advances in cell and gene therapies, and the unprecedented success of vaccines based on nucleic acid seen during the Covid pandemic, the need for high quality plasmid ...
QC in ATMP production: Sailing a stormy sea, what’s the key?
Medicines based on genes, cells, or tissue engineering, i.e. Advanced Therapy Medicinal Products (ATMPs) are a rising star shining brighter and brighter in the horizon for any CDMO operating in ...
Move your product forward with nordic expertise in vaccine, cell, and gene therapies
NorthX Biologics offers comprehensive solutions in plasmid DNA, protein manufacturing, virus and viral vectors, cell therapy, aseptic fill/finish, and mRNA services. Located in the heart of Sweden, we have been ...
NorthX Biologics – A new kind of biologics company
NorthX Biologics is an established provider of process development and manufacturing services with expertise in the biologics used in vaccines, gene therapy and other advanced applications. Headquartered in Matfors in ...
Finding your match in the biotech world: The CDMO dating game
In the dynamic and complex world of pharmaceuticals and drug development, the quest to find the right Contract Development and Manufacturing Organization (CDMO) often feels akin to searching for a ...
Navigating the production of non-GMP proteins in a GMP-driven environment
As the pharmaceutical and biotechnological industries are obliged to align their operations with Good Manufacturing Practice (GMP) guidelines, a unique set of challenges emerges for facilities tasked with producing non-GMP ...
Check out the new conference insight on what’s cooking in the ATMP space
Current trends in ATMPs This article is written by NorthX Biologics Senior Advisor Helena Strigård och Bio-works Technologies CEO Jonathan Royce. Link to Article